Abstract
Increases in sexually transmitted diseases (STDs) among men who have sex with men (MSM) have coincided with recent increases in sexual risk behaviors across the United States and Europe. The identification of same-sex sexual risk behavior in men and the subsequent risk for certain bacterial and viral infections requires competency in taking a sexual history. Recent advances in the diagnosis and treatment of STDs have made STD management easier for physicians and patients and expanded the ability of a variety of health care professionals to participate in the management of STDs. This review focuses on recent developments in the epidemiology, pathogenesis, diagnosis, and management of common STDs in MSM.
Similar content being viewed by others
References and Recommended Reading
Scheer S, Chu PL, Klausner JD, et al.: Effect of highly active antiretroviral therapy on diagnoses of sexually transmitted diseases in people with AIDS. Lancet 2001, 357:432–435.
Stall RD, Hays RB, Waldo CR, et al.: The Gay 90′s: a review of research in the 1990s on sexual behavior and HIV risk among men who have sex with men. AIDS 2000, 14(Suppl 3):S101-S114. This paper reviews the recent sexual behavioral research and STD/HIV risk among MSM, including behavioral trends, identified vulnerable subgroups, and associated variables for sexual risk taking among MSM.
Klausner JD, Wolf W, Fischer-Ponce L, et al.: Tracing a syphilis outbreak through cyberspace. JAMA 2000, 284:447–449.
Kim A, Kent C, Klausner JD: Increased risk of HIV and sexually transmitted disease transmission among gay or bisexual men who use Viagra, San Francisco 2000–2001. AIDS 2002, 16:1425–1428.
Kim A, Kent C, Klausner JD: An investigation of rectal gonorrhea among men who have sex with men in San Francisco, 2000. Paper presented at 2000 National STD Prevention Conference - Untapped Opportunities: Connecting Science with Solutions. Milwaukee. December 4–7, 2000.
Colfax GN, Mansergh G, Guzman R, Vittinghoff E, et al.: Drug use and sexual risk behavior among gay and bisexual men who attend circuit parties: A venue-based comparison. J Acquir Immune Defic Syndr 2001, 28:373–379.
Klausner JD, Kim A, Kent C: Are HIV drug advertisements contributing to increases in risk behavior among men in San Francisco, 2001? AIDS 2002, 16:15–16.
Centers for Disease Control and Prevention: Sexually transmitted diseases treatment guidelines, 2002. MMWR 2002, 51:1–78. These evidence-based updated guidelines were developed by the CDC to provide recommendations for the treatment and counseling of individual patients with STDs.
Klausner JD, Kim A, Kent C: America Online perpetuates syphilis and gonorrhea transmission in San Francisco. Paper presented at 2002 National STD Prevention Conference. San Diego. March 4–7, 2002.
Dilley JW, Loeb L, Casey S, et al.: Introducing anonymous screening for sexually transmitted infections at an anonymous HIV test site. Paper presented at XIV International AIDS Conference. Barcelona. July 7–12, 2002.
Page-Shafer K, Graves A, Kent C, et al.: Increased sensitivity of DNA amplification testing for the detection of pharyngeal gonorrhea in men who have sex with men. Clin Infect Dis 2002, 34:173–176.
Bauer HM, Vannier A, Moore D, et al.: Ciprofloxacin-resistant Neisseria gonorrhoeae in Southern California, 2000–2001: are men who have sex with men at greater risk? Paper presented at 2002 National STD Prevention Conference. San Diego. March 4–7, 2002.
Ciemins EL, Flood J, Kent CK, et al.: Reexamining the prevalence of Chlamydia trachomatis infection among gay men with urethritis: Implications for STD policy and HIV prevention activities. Sex Transm Dis 2000, 27:249–251. High chlamydial infection rates were observed among MSM attending an STD clinic, resulting in changes to clinical practice guidelines that included routine chlamydia screening for urethral infection, and diagnostic testing in MSM with urethritis.
Geisler WM, Whittington WLH, Suchland RJ, et al.: Epidemiology of anorectal chlamydial and gonococcal infections among men having sex with men in Seattle. Sex Transm Dis 2002, 29:189–195. This article describes the epidemiology and clinical manifestations of anorectal chlamydial and gonococcal infections among MSM in Seattle using serovar and auxotype typing of strains and a case-control study design to identify behavioral and sociodemographic predicators of infection. Increased prevalence of anorectal chlamydial infection and gonorrhea among MSM was noted, and increases were due to the spread of unique distributions of strains that differ from those causing urogenital infections in the same community.
Klausner JD, Kohn R, Kent C: Etiology of sexually transmitted proctitis in men, San Francisco, 2001. Paper presented at 40th Annual Meeting of the IDSA. Chicago. October 25–27, 2002.
Hammel MJ, Judson FN, Rietmeijer CA: Screening for chlamydia trachomatis in a anonymous and confidential HIV counseling and testing site: feasibility and prevalence rates. Sex Transm Dis 2001, 28:153–157.
Klausner JD, Kohn R, Kent C: Increased prevalence of Chlamydia trachomatis rectal infections with nucleic acid amplification testing: implications for screening. Paper presented at 40th Annual Meeting of the IDSA. Chicago. October 25–27, 2002.
Cook RL, St. George K, Slivestre AJ, et al.: Prevalence of chlamydia and gonorrhoea among a population of men who have sex with men. Sex Transm Infect 2002, 78:190–193.
Golden MR, Astete SG, Celum CW, et al.: Comparison of specimen-processing procedures and preliminary data on performance of the ROCHE COBAS PCR to detect chlamydia trachomatis (CT) in rectal specimens. Paper presented at 2002 National STD Prevention Conference. San Diego. March 4–7, 2002.
Somani J, Bhullar VB, Workowski KA, et al.: Multiple drugresistant Chlamydia trachomatis associated with clinical treatment failure. J Infect Dis 2000, 181:1421–1427.
Williams LA, Klausner JD, Whittington WLH, et al.: Elimination and reintroduction of primary and secondary syphilis. Am J Public Health 1999, 89:1093–1097.
Cohen DE, Mayer KH, Feuer JC, et al.: Increasing rates of syphilis and gonorrhea among men who have sex with men (MSM) at a Boston community health center, 1997–1999. Paper presented at 38th Annual Meeting of the Infectious Diseases Society of America. New Orleans. September 7–10, 2000.
Ciesielski CA, Boghani S, Simmons C: The evolving picture of syphilis in Chicago. In International Congress of Sexually Transmitted Infections, ISSTDR/IUSTI. Berlin, Germany: The Royal Society of Medicine; 2001.
Chen JL, Kodagoda D, Lawrence AM, Kerndt PR: Rapid public health interventions in response to an outbreak of syphilis in Los Angeles. Sex Transm Dis 2002, 29:285–287.
Centers for Disease Control and Prevention: Primary and secondary syphilis among men who have sex with men—New York City, 2001. MMWR 2002, 51:853–856.
Small R, Goldberg M, Eberhart M: Syphilis outbreak among men who have sex with men (MSM) - Philadelphia, PA. Paper presented at 2000 National STD Prevention Conference - Untapped Opportunities: Connecting Science with Solutions. Milwaukee. December 4–7, 2000.
Chen SY, Gibson S, Katz MH, et al.: Continuing increases in sexual risk behavior and sexually transmitted diseases among men who have sex with men: San Francisco, CA, 1999–2001, USA. Am J Public Health 2002, 92:1387–1388. Using data from serial cross-sectional surveys of MSM in a variety of community settings, this report documents increases in sexual risk behavior and rectal gonorrhea and early syphilis among MSM in San Francisco.
Centers for Disease Control and Prevention: Outbreak of syphilis among men who have sex with men—Southern California. MMWR 2000, 50:12–14.
Centers for Disease Control and Prevention: Resurgent bacterial sexually transmitted disease among men who have sex with men-King county, Washington, 1997–1999. MMWR 1999, 48:773–777.
Ciesielski CA, Flynn J, Zajackowski M: Knowledge and awareness of syphilis among different populations of men who have sex with men. In International Congress of Sexually Transmitted Infections, ISSTDR/IUSTI. Berlin, Germany: The Royal Society of Medicine Press; 2001.
Rompalo AM, Lawlor J, Seaman P, et al.: Modification of syphilitic genital ulcer manifestations by coexistent HIV infection. Sex Transm Dis 2001, 28:448–454.
Rolfs RT, Joesoef MR, Hendershott EF, et al.: A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med 1997, 337:307–314.
Marra CM, Maxwell CL, Smith SL, et al.: Risk factors for neurosyphilis. Paper presented at 2002 National STD Prevention Conference. San Diego. March 4–7, 2002.
Hook EW, Stephens J: Azithromycin compared with penicillin G benzathine for treatment of incubating syphilis. Ann Intern Med 1999, 131:434–437.
Hook EW, Martin DH, Stephens J, et al.: A randomized, comparative pilot study of azithromycin versus benzathine penicillin G for treatment of early syphilis. Sex Transm Dis 2000 29:486–490.
Wawer MJ, Sewankambo NK, Servadda D, et al.: Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Lancet 1999, 353:525–535.
Rekart ML, Patrick DM, Chakraborty B, et al.: A Trial of Mass Treatment with Oral Azithromycin to Control an Outbreak of Syphilis. Vancouver: University of British Columbia, British Columbia Centre for Disease Control; 2002.
Totten PA, Schwartz MA, Sjostrom KE, et al.: Association of Mycoplasma genitalium with nongonococcal urethritis in heterosexual men. J Infect Dis 2001, 183:269–276.
Xu F, Sternberg MR, Karem K, et al.: Association between MSM behavior and the seroprevalence of HPV-16 and HSV-2. Paper presented at 2002 National STD Prevention Conference. San Diego. March 4–7, 2002.
Lafferty WE, Downey L, Celum C, et al.: Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention. J Infect Dis 2000, 181:1454–1457.
Dolce P, Alarie I, Bernatchez H, et al.: Increased prevalence and predominance of herpes simplex virus (HSV) type 1 in genital herpes infection. Paper presented at 38th Annual Meeting of the Infectious Diseases Soceity of America. New Orleans. September 7–10, 2000.
Turner K, Hammer G, Kent C, et al.: Trends in genital herpes simplex virus infections among San Francisco STD clinic attendees, 1995–1999. Paper presented at 38th Annual Meeting of the Infectious Diseases Society of America. New Orleans. September 7–10, 2000.
Xu F, Schillinger JA, Sternberg MR, et al.: Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988–1994. J Infect Dis 2002, 185:1019–1024.
Krone MR, Tabet SR, Paradise M, et al.: Herpes simplex virus shedding among human immunodeficiency virus-negative men who have sex with men: site and frequency of shedding. J Infect Dis 1998, 178:978–982.
Krone MR, Wald A, Tabet S, et al.: Herpes simplex virus type 2 shedding in human immunodeficiency virus-negative men who have sex with men: frequency, patterns and risk factors. Clin Infect Dis 2000, 30:261–267. This article summarizes the results from a prospective cohort study to evaluate the frequency, site, and risk factors for clinical and subclinical HSV-1 and HSV-2 shedding among HIV-negative MSM.
Wald A, Carrel D, Remington M, Kexel E: Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection. Clin Infect Dis 2002, 34:944–948.
MacKellar DA, Valleroy LA, Secura GM, et al.: Two decades after vaccine license: Hepatitis B immunization and infection among young men who have sex with men. Am J Public Health 2001, 91:965–971.
Jacobs RJ, Meyerhoff AS: Vaccination of sexually active homosexual men against hepatitis A: anaylsis of costs and benefits. J Gay Lesbian Med Assoc 1999, 3:2.
Buchbinder S, Katz MH, Hessol NA, et al.: Hepatitis C virus infection in sexually active homosexual men. J Infection 1994, 29:263–269.
Hammer G, Kellog TA, McFarland WC, et al.: Low incidence of hepatitis C virus infection among sexually active non-injection drug using adults seeking anonymous HIV counseling and testing in San Francisco, 1997–2000. San Francisco STD Monthly Report; 2003.
Management of Hepatitis C: 2002. National Institutes of Health Consensus Development Conference Statement. June 10–12, 2002.
Edwards L, Ferenczy A, Eron L, et al.: Self-administered topical 5% imiquimod cream for external anogenital warts. Arch Dematol 1998, 134:25–30.
Palefsky JM: Human papillomavirus-related tumors. AIDS 2000, 14(Suppl 3):S189-S195.
Koutsky LA, Ault KA, Wheeler CM, et al.: A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002, 347:1656–1661.
Quinn T, Stamm WE, Goddell SE, et al.: The polymicrobial origin of intestinal infections in homosexual men. N Engl J Med 1983, 309:576–582.
Centers for Disease Control and Prevention: Large Shigella sonnei outbreak among men who have sex with men, San Francisco, 2000. MMWR 2001, 50:922–926.
Vugia DJ, Shallow S, Samuel MC, et al.: Risk factors for shigellosis in San Francisco adults. Paper presented at 38th Annual Meeting of the Infectious Diseases Society of America. New Orleans. September 7–10 2000.
Rossignol JF, Ayoub A, Ayers MS: Treatment of diarrhea caused by cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of nitazoxanide. J Infect Dis 2001, 184:103–106.
Replogle MF, Flemming DW, Cieslak PR: Emergence of antimicrobial-resistant shigellosis in Oregon. Clin Infect Dis 2000, 30:515–519.
Cameron DW, Simonsen JN, D’Costa LJ, et al.: Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men. Lancet 1989, 2:403–407.
Grosskurth H, Mosha F, Todd J, et al.: Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomized controlled trial. Lancet 1995, 346:530–536.
Cohen M, Hoffman IF, Royce RA, et al.: Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. Lancet 1997, 349:1868–1873.
Anzala AO, Simonsen JN, Kimani J, et al.: Acute sexually transmitted infections increase human immunodeficiency virus type 1 plasma viremia, increase plasma type 2 cytokines, and decrease CD4 cell counts. J Infect Dis 2000, 182:459–466.
Craib K, Meddings DR, Strathdee SA, et al.: Rectal gonorrhea as an independent risk factor for HIV infection in a cohort of homosexual men. Genitourin Med 1995, 71:150–154.
Schwarcz S, Kellogg TA, McFarland W, et al.: Characterization of sexually transmitted disease clinic patients with recent human immunodeficiency virus infection. J Infect Dis 2002, 186:1019–1022.
California STD Controllers Association and California Coalition of Local AIDS Directors: Guidance for STD clinical preventive services for persons infected with HIV. Sex Transm Dis 2001, 28:460–463. This article provides useful recommendations for STD screening and clinical preventive services for persons infected with HIV, including specific recommendations on risk assessment and health education, diagnostic and treatment issues, and guidance on client-centered risk reduction counseling for STD/HIV prevention.
STD Control Program, Public Health-Seattle King County: Sexually transmitted disease and hiv screening guidelines for men who have sex with men. Sex Transm Dis 2001, 28:457–459. This article provides STD and HIV screening recommendations for MSM developed by Public Health, Seattle and King County, WA. These recommendations were based on STD prevalence and behavioral risk studies in Seattle and King County, WA.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Klausner, J.D., Wong, W. Sexually transmitted diseases in men who have sex with men: A clinical review. Curr Infect Dis Rep 5, 135–144 (2003). https://doi.org/10.1007/s11908-003-0050-6
Issue Date:
DOI: https://doi.org/10.1007/s11908-003-0050-6